Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)

OBJECTIVES: To re-examine the use of non-carbapenems (NCBPs), specifically piperacillin/tazobactam and cefepime, for ESBL-producing Enterobacterales (ESBL-E) urinary tract infections (UTIs). PATIENTS: Retrospective cohort study of adults hospitalized between January 2016 and June 2020 with pyuria on...

Descripción completa

Detalles Bibliográficos
Autores principales: Branton, Alexander C, Vu, Catherine H, Venugopalan, Veena, Santevecchi, Barbara A, Cherabuddi, Kartikeya, Ramphal, Reuben, Manohar, Tanvi, Desear, Kathryn E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020980/
https://www.ncbi.nlm.nih.gov/pubmed/36936190
http://dx.doi.org/10.1093/jacamr/dlad021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020980/
https://www.ncbi.nlm.nih.gov/pubmed/36936190
http://dx.doi.org/10.1093/jacamr/dlad021

Ejemplares similares